CA, Gielen AC Social elements related to syringe sharing among injecting partners: a focus on gender. Subst Use Misuse 36: 21132136. 25. Smyth 1317923 BP, Barry J, Keenan E Syringe borrowing persists in Dublin despite harm reduction interventions. Addiction 96: 717727. 26. Smyth BP, Roche A Recipient syringe sharing and its connection to social BIBS39 biological activity proximity, perception of threat and preparedness to share. Addict Behav doi:ten.1016/j.addbeh.2006.12.021. 27. Needle RH, Coyle S, Cesari H, Trotter R, Clatts M, et al. HIV danger behaviours associated together with the injection process: multiperson use of drug injection equipment and paraphernalia in injection drug user networks. Subst Use Misuse 33: 24032423. 28. Aral SO Behavioral aspects of sexually transmitted diseases: core groups and bridge populations. Sex Transm Dis 27: 327328. 29. Watts C, Zimmerman C, Foss AM, Hossain M, Cox A, et al. Remodelling core group theory: the function of sustaining populations in HIV transmission. Sex Transm Infect 86 Suppl 3: iii8592. 30. Des Lecirelin chemical information Jarlais DC, Arasteh K, Perlis T, Hagan H, Abdul-Quader A, et al. Convergence of HIV seroprevalence amongst injecting and non-injecting drug users in New York City. AIDS 21: 231235. 31. Hagan H Hepatitis C virus transmission dynamics in injection drug users. Substance Use and Misuse 33: 11971212. 32. Hagan H, Des Jarlais 18204824 DC HIV and HCV infection among injecting drug users. Mt Sinai J Med 67: 423428. 33. Des Jarlais DC Decreasing syringe sharing among injection drug users in Winnipeg: 81% accomplishment or 19% failure Addiction 102: 1636. 34. Shaw SY, Deering KN, Jolly AM, Wylie JL Elevated risk for hepatitis C associated with solvent use amongst Canadian Aboriginal injection drug users. Harm Reduction Journal 7: 16. 35. Dell CA, Dell DE, Hopkins D Resiliency and holistic inhalant abuse remedy. Journal of Aboriginal Overall health 2: 413. 36. Byrne A, Kirby B, Zibin T, Ensminger S Psychiatric and neurological effects of chronic solvent abuse. Can J Psychiatry 36: 735738. 37. Schutz CG, Chilcoat HD, Anthony JC The association involving sniffing inhalants and injecting drugs. Comprehensive Psychiatry 35: 99105. 38. Johnson EO, Schutz CG, Anthony JC, Ensminger ME Inhalants to heroin: a potential analysis from adolescence to adulthood. Drug and Alcohol Dependence 40: 159164. 39. Latkin CA, Mandell W, Vlahov D, Oziemkowska M, Celentano D Men and women and places: behavioural settings and personal network characteristics as correlates of needle sharing. J Acquir Immune Defic Syndr Hum Retrovirol 13: 273280. 40. Aday LA Well being status of vulnerable populations. Annu Rev Public Well being 15: 487509. 41. Dean HD, Steele CB, Satcher AJ, Nakashima AK HIV/AIDS amongst minority races and ethnicities in the Usa, 19992003. J Natl Med Assoc 97: 5S12S. 42. Han B, Gfroerer JC, Colliver JD Associations involving duration of illicit drug use and overall health conditions: results from the 20052007 national surveys on drug use and overall health. Ann Epidemiol 20: 289297. 43. Garland EL, Howard MO, Vaughn MG, Perron BE Volatile substance misuse inside the Usa. Substance Use and Misuse 46 Suppl 1: 820. 44. De P, Jolly A, Cox J, Boivin JF Characterizing the drug-injecting networks of cocaine and heroin injectors in Montreal. Can J Public Health 97: 207209. 45. Shaw SY, Shah L, Jolly AM, Wylie JL Identifying heterogeneity among intravenous drug customers: a cluster evaluation approach. American Journal of Public Wellness 98: 14301437. 46. Marshall BD, Wood E, Shoveller JA, Buxton JA, Montaner JS, et al. Indi.CA, Gielen AC Social elements related to syringe sharing amongst injecting partners: a focus on gender. Subst Use Misuse 36: 21132136. 25. Smyth 1317923 BP, Barry J, Keenan E Syringe borrowing persists in Dublin regardless of harm reduction interventions. Addiction 96: 717727. 26. Smyth BP, Roche A Recipient syringe sharing and its partnership to social proximity, perception of threat and preparedness to share. Addict Behav doi:ten.1016/j.addbeh.2006.12.021. 27. Needle RH, Coyle S, Cesari H, Trotter R, Clatts M, et al. HIV risk behaviours connected with the injection course of action: multiperson use of drug injection gear and paraphernalia in injection drug user networks. Subst Use Misuse 33: 24032423. 28. Aral SO Behavioral aspects of sexually transmitted illnesses: core groups and bridge populations. Sex Transm Dis 27: 327328. 29. Watts C, Zimmerman C, Foss AM, Hossain M, Cox A, et al. Remodelling core group theory: the function of sustaining populations in HIV transmission. Sex Transm Infect 86 Suppl 3: iii8592. 30. Des Jarlais DC, Arasteh K, Perlis T, Hagan H, Abdul-Quader A, et al. Convergence of HIV seroprevalence amongst injecting and non-injecting drug users in New York City. AIDS 21: 231235. 31. Hagan H Hepatitis C virus transmission dynamics in injection drug users. Substance Use and Misuse 33: 11971212. 32. Hagan H, Des Jarlais 18204824 DC HIV and HCV infection among injecting drug customers. Mt Sinai J Med 67: 423428. 33. Des Jarlais DC Minimizing syringe sharing amongst injection drug customers in Winnipeg: 81% success or 19% failure Addiction 102: 1636. 34. Shaw SY, Deering KN, Jolly AM, Wylie JL Elevated risk for hepatitis C connected with solvent use amongst Canadian Aboriginal injection drug customers. Harm Reduction Journal 7: 16. 35. Dell CA, Dell DE, Hopkins D Resiliency and holistic inhalant abuse remedy. Journal of Aboriginal Overall health 2: 413. 36. Byrne A, Kirby B, Zibin T, Ensminger S Psychiatric and neurological effects of chronic solvent abuse. Can J Psychiatry 36: 735738. 37. Schutz CG, Chilcoat HD, Anthony JC The association among sniffing inhalants and injecting drugs. Complete Psychiatry 35: 99105. 38. Johnson EO, Schutz CG, Anthony JC, Ensminger ME Inhalants to heroin: a prospective analysis from adolescence to adulthood. Drug and Alcohol Dependence 40: 159164. 39. Latkin CA, Mandell W, Vlahov D, Oziemkowska M, Celentano D Folks and areas: behavioural settings and private network qualities as correlates of needle sharing. J Acquir Immune Defic Syndr Hum Retrovirol 13: 273280. 40. Aday LA Wellness status of vulnerable populations. Annu Rev Public Health 15: 487509. 41. Dean HD, Steele CB, Satcher AJ, Nakashima AK HIV/AIDS among minority races and ethnicities within the United states, 19992003. J Natl Med Assoc 97: 5S12S. 42. Han B, Gfroerer JC, Colliver JD Associations amongst duration of illicit drug use and wellness conditions: final results in the 20052007 national surveys on drug use and health. Ann Epidemiol 20: 289297. 43. Garland EL, Howard MO, Vaughn MG, Perron BE Volatile substance misuse inside the United states of america. Substance Use and Misuse 46 Suppl 1: 820. 44. De P, Jolly A, Cox J, Boivin JF Characterizing the drug-injecting networks of cocaine and heroin injectors in Montreal. Can J Public Overall health 97: 207209. 45. Shaw SY, Shah L, Jolly AM, Wylie JL Identifying heterogeneity among intravenous drug users: a cluster evaluation approach. American Journal of Public Well being 98: 14301437. 46. Marshall BD, Wood E, Shoveller JA, Buxton JA, Montaner JS, et al. Indi.
